Transmembrane protein 121 (TMEM121)

Transmembrane protein 121 (TMEM121) is a six-transmembrane domain protein encoded by the TMEM121 gene, also known as HOLE, TMEM121A, and other aliases[1][4]. It is expressed in several tissues, notably the heart, where it is implicated in cardiac development and plays a cardioprotective role by attenuating pathological remodeling and hypertrophy via suppression of ERK1/2 signaling[1]. TMEM121 also appears to be involved in cancer biology, particularly as a potential tumor suppressor in cervical cancer, where its downregulation (likely related to promoter hypermethylation) is associated with increased cell proliferation and migration and altered PI3K/AKT pathway activity[3]. While it is involved in critical signaling pathways and disease processes, there is no current evidence categorizing TMEM121 as a conventional therapeutic “target” such as a receptor, enzyme, ion channel, or transporter, nor are there any known drugs that directly interact with TMEM121[1][3][4].\n\nTMEM121’s primary biological roles include regulation of cardiac morphogenesis and protective effects against cardiac hypertrophy, as well as potential inhibitory action on migration and proliferation in cervical cancer cells through interaction with key signaling pathways such as MAPK and PI3K/AKT[1][3][4]. Associations with congenital heart disease have been identified through specific genetic polymorphisms[1]. The function of TMEM121 in other disease contexts remains underexplored, and it is classified primarily as a general transmembrane protein rather than a receptor or other class of druggable target.\n\nNo validated safety concerns or clinically actionable drug interactions are known at this time[1][3][4].

Other names

HOLETMEM121AHHOLEMGC4659holehholetransmembrane protein 121A